Cartalax (25 mg Vial)
25 mg Research Peptide
Quick Facts
- Type
- Single
- Category
- Recovery / Healing
- Vial Strength
- 25 mg
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete Cartalax 25mg research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
What Is Cartalax 25mg?
Cartalax 25mg Vial Overview
Cartalax (Ala-Glu-Asp) is a bioregulatory tripeptide targeting cartilage tissue and musculoskeletal function at the gene-expression level. It modulates genes involved in chondrocyte proliferation, extracellular matrix synthesis, and tissue repair, representing a gene-regulatory approach to cartilage regeneration research.
Cartalax 25mg Quick Reference
Cartalax 25mg Vial Specifications
- Peptide
- Cartalax (25 mg Vial) (NNMT inhibitor)
- Vial Content
- 25 mg total peptide
- Category
- Recovery / Healing
- Administration Method
- Subcutaneous injection or oral
- Common Use Case
- Cartilage and musculoskeletal support
Cartalax 25mg Compared With Other Formats
Details that distinguish this 25 mg format include:
- Targeted cartilage bioregulator
- Gene-regulatory approach
- Part of Khavinson system
How Does Cartalax Work?
Cartalax Mechanism of Action
Cartalax (Ala-Glu-Asp) is a bioregulatory tripeptide that modulates genes involved in chondrocyte proliferation, extracellular matrix synthesis, and cartilage tissue repair at the epigenetic level.
What Are the Potential Benefits of Cartalax?
Cartalax Research Findings and Observed Outcomes
Findings and reported areas of study for Cartalax (25 mg Vial) include:
- Chondrocyte proliferation support
- ECM synthesis enhancement
- Cartilage repair promotion
- Musculoskeletal function
These observations are discussed for research and educational reference only and are not medical claims.
What Do You Need to Reconstitute Cartalax 25mg?
Cartalax 25mg Supplies for Reconstitution and Handling
- •Insulin syringes (29–31g)
- •Bacteriostatic water
- •Alcohol prep pads
- •Sharps container
Supplies listed are for laboratory handling and research preparation purposes only.
Cartalax 25mg Administration and Research Protocol
Cartalax Injection Route, Frequency and Timing
Cartalax 25mg Dosage Guide
Cartalax Dosage Ranges
The ranges below pair the listed dose with the draw volume for this product strength.
Cartalax 25mg Dosage to Syringe Units
Based on reconstitution below
| Target Daily Dose | Draw Volume | Units |
|---|---|---|
| 5 mg | 0.25 mL | 25 units |
| 10 mg | 0.50 mL | 50 units |
This dosing table is unique to the 25 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).
How Long Does a Cartalax 25mg Vial Last?
Cartalax 25mg Duration by Research Dose
At common research doses, one 25 mg vial of Cartalax typically supports:
10–20 day cycles, 2–3 times per year.
How to Reconstitute Cartalax 25mg
Cartalax 25mg Reconstitution With Bacteriostatic Water
This section applies specifically to the Cartalax (25 mg Vial).
- Recommended Diluent
- Bacteriostatic water
- Diluent Volume
- 1.25 mL
- Final Concentration
- 20 mg/mL
Cartalax 25mg Mixing Instructions
- 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
- 2Wash hands thoroughly and prepare a clean workspace with all supplies.
- 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
- 4Clean the rubber stopper of the vial with an alcohol prep pad.
- 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
- 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
- 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.
Cartalax Stacks and Research Combinations
Cartalax and Compatible Research Pairings
In research settings, Cartalax (25 mg Vial) is sometimes paired with peptides such as:
Factors That May Affect Cartalax Research Outcomes
Supporting Factors for Cartalax Research
Factors recorded alongside this protocol include:
- Joint-supportive exercise
- Collagen-rich nutrition
- Adequate hydration
These factors can affect how research observations are interpreted.
Cartalax Side Effects and Safety Considerations
Cartalax 25mg Tolerability Notes
Well-tolerated bioregulator.
Some individuals report:
- Mild injection site reactions
How to Store Cartalax Before and After Reconstitution
Cartalax 25mg Storage Requirements
- Unreconstituted
- Refrigerate
- Reconstituted
- Refrigerate at 2–8°C
- Post-Mix Stability
- Up to 4 weeks
Who Should Avoid Cartalax?
This peptide is generally not recommended for:
- Pregnant/breastfeeding
Cartalax 25mg FAQs
Can Cartalax help with arthritis?
Cartalax is studied for cartilage gene regulation, not as an arthritis treatment. It supports chondrocyte function at the epigenetic level.
Where to Buy Cartalax 25mg for Research
Cartalax 25mg Purchasing and Research Supply Notes
Before ordering Cartalax (25 mg Vial), review the product label, available testing documents, and storage instructions.
Check the ResearchLabs listing for:
- Available testing documents
- Product strength and concentration
- Storage and handling instructions
- Current product availability
Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.
Cartalax (25 mg Vial)
25 mg Research Peptide
Quick Facts
- Type
- Single
- Category
- Recovery / Healing
- Vial Strength
- 25 mg
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete Cartalax 25mg research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
